Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 18;51(4):e20250066.
doi: 10.36416/1806-3756/e20250066. eCollection 2025.

Influence of ADRB2 variants on bronchodilator response and asthma control in a mixed population

Affiliations

Influence of ADRB2 variants on bronchodilator response and asthma control in a mixed population

Pedro Augusto Silva Dos Santos Rodrigues et al. J Bras Pneumol. .

Abstract

Objective: Given that b2 agonists constitute the primary treatment for asthma and that treatment response varies as a result of polymorphisms in the ADRB2 gene, we sought to investigate the associations between ADRB2 gene variants and bronchodilator response (BDR) in asthma patients.

Methods: A genetic database comprising 813 individuals was analyzed for variants in the ADRB2 gene. A longitudinal analysis of severe asthma patients was performed to evaluate changes in BDR over time.

Results: The rs1042713, rs1042714, and rs1042717 variants were associated with age-related changes in BDR in patients with severe asthma. The G allele (rs1042714) and the A allele (rs1042717) were associated with uncontrolled asthma, with carriers of the G46/G79/A252 alleles showing a higher risk of difficult-to-control asthma. Notably, no association was found between these variants and ADRB2 expression levels.

Conclusions: Our findings suggest that a genetic panel including ADRB2 variants, as well as age-related differences in BDR, is a useful complementary tool in asthma management.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: None declared.

Figures

Figure 1
Figure 1. Correlation between rs1042713 and variations in longitudinal bronchodilator response. In A, overlaid smooths with a shaded area stratified by the number of A alleles-0, 1, or 2-and bronchodilator response adjusted for covariates. In B, density graphs for individuals stratified by bronchodilator response, grouped by number of A alleles and age.
Figure 2
Figure 2. Correlation between rs1042714 and variations in longitudinal bronchodilator response. In A, overlaid smooths with a shaded area stratified by the number of G alleles-0, 1, or 2-and bronchodilator response adjusted for covariates. In B, density graphs for individuals stratified by bronchodilator response, grouped by number of A alleles and age.

Similar articles

References

    1. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi: 10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
    1. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA. Global asthma prevalence in adults findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204–204. doi: 10.1186/1471-2458-12-204. - DOI - PMC - PubMed
    1. Cruz AA, Riley JH, Bansal AT, Ponte EV, Souza-Machado A, Almeida PCA. Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status. Respir Med. 2020;161:105817–105817. doi: 10.1016/j.rmed.2019.105817. - DOI - PubMed
    1. Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and Overdiagnosis of Asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020. doi: 10.1164/rccm.201804-0682CI. - DOI - PubMed
    1. Mortimer K, Reddel HK, Pitrez PM, Bateman ED. Asthma management in low- and middle-income countries case for change. Eur Respir J. 2022;60(3):103179–103179. doi: 10.1183/13993003.03179-2021. - DOI - PMC - PubMed

Substances